Induction of hepatic veno-occlusive disease in dogs.
暂无分享,去创建一个
H. Deeg | R. Storb | H. Shulman | K. Luk | William Shuman
[1] K. Sullivan,et al. Intestinal and hepatic complications of human bone marrow transplantation. Part I. , 1986, Gastroenterology.
[2] W. Haddon,et al. trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine. , 1985, Science.
[3] Pankaj Sharma,et al. THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION , 1985, Transplantation.
[4] J. Geraci,et al. Hepatic injury after whole-liver irradiation in the rat. , 1985, Radiation research.
[5] G. T. Bowden,et al. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. , 1984, Cancer research.
[6] L. Harker,et al. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. , 1984, The Journal of clinical investigation.
[7] Pankaj Sharma,et al. Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.
[8] E. W. Bradley,et al. Pathologic effects of fractionated fast neutrons or photons on the pancreas, pylorus and duodenum of dogs. , 1983, International journal of radiation oncology, biology, physics.
[9] H. Deeg,et al. High-dose total-body irradiation and autologous marrow reconstitution in dogs: dose-rate-related acute toxicity and fractionation-dependent long-term survival. , 1981, Radiation research.
[10] E. W. Bradley,et al. The pathologic effects of fractionated fast neutrons or photons on canine liver. , 1981, Cancer clinical trials.
[11] K. Kopecky,et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. , 1980, Gastroenterology.
[12] L. F. Fajardo,et al. Pathogenesis of veno-occlusive liver disease after radiation. , 1980, Archives of pathology & laboratory medicine.
[13] J. Boitnott,et al. Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. , 1980, The American journal of pathology.
[14] A. Meister,et al. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.
[15] E. W. Bradley,et al. Effects of fractionated doses of fast neutrons and photons on the normal canine lung: relative biological effectiveness values obtained by radionuclide studies. , 1979, International journal of radiation oncology, biology, physics.
[16] T. Mcelwain,et al. Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep. , 1978, European journal of cancer.
[17] W. Bleyer. The clinical pharmacology of methotrexate. new applications of an old drug , 1978, Cancer.
[18] R. Storb,et al. Dimethyl myleran and autologous marrow grafting for the treatment of spontaneous canine lymphoma. , 1977, European journal of cancer.
[19] R. Heyn,et al. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems , 1976, Cancer.
[20] H. Ochs,et al. Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran. , 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[21] M. P. Mitchell,et al. Studies on the cytotoxicity of Myleran and dimethyl Myleran. , 1972, Canadian journal of biochemistry.
[22] E. McLean. The toxic actions of pyrrolizidine (senecio) alkaloids. , 1970, Pharmacological reviews.
[23] R. Storb,et al. Marrow infusions in dogs given midlethal or lethal irradiation. , 1970, Radiation research.
[24] J. Allen,et al. Hepatic veins of monkeys with veno-occlusive disease. Sequential ultrastructural changes. , 1969, Archives of pathology.